Published on European Cystic Fibrosis Society (ECFS) (https://www.ecfs.eu)

Home > Examining the potential for drug interactions with Trikafta®/Kaftrio® in people with cystic fibrosis

Examining the potential for drug interactions with Trikafta®/Kaftrio® in people with cystic fibrosis

Resource Type

CF Research News

Authors

Debanjali Purkayastha, Kyla Agtarap, Kristy Wong, Onella Pereira, Jannie Co, Smita Pakhale, Salmaan Kanji

References

J Cyst Fibros. 2023 Jan 16;S1569-1993(23)00004-8. doi: 10.1016/j.jcf.2023.01.005.

Document

PDF icon CF Research News Article [1]

Link

Scientific Abstract [2]

Theme

Care of patients with CF [3]

Keywords

CFTR modulator [4]
Drug interactions [5]
Elexacaftor [6]
Ivacaftor [7]
Pharmacokinetics [8]
Tezacaft [9]

Date

Monday, January 16, 2023

Featured resource article

Yes

Resource - Guideline Type

Other Guidelines [10]
Source URL:https://www.ecfs.eu/resource-article/cf-research-news/examining-potential-drug-interactions-trikafta%C2%AEkaftrio%C2%AE-people

Links
[1] https://www.ecfs.eu/sites/default/files/cf-research-article-files/JCF-D-22-00259R2_FINAL_Kanji_260223.pdf [2] https://pubmed.ncbi.nlm.nih.gov/36653239/ [3] https://www.ecfs.eu/research-article-themes/care-patients-cf [4] https://www.ecfs.eu/research-article-keywords/cftr-modulator [5] https://www.ecfs.eu/research-article-keywords/drug-interactions [6] https://www.ecfs.eu/research-article-keywords/elexacaftor [7] https://www.ecfs.eu/research-article-keywords/ivacaftor [8] https://www.ecfs.eu/research-article-keywords/pharmacokinetics [9] https://www.ecfs.eu/research-article-keywords/tezacaft [10] https://www.ecfs.eu/resource-guideline-type/other-guidelines